[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Night Owl Biotech Research Group [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) on x 1157 followers Created: 2025-06-29 20:45:38 UTC A $SNDX $INCY Niktimvo revenue forecast using $RPRX data points per its 11/24 investor pres. RPRX notes its $350MM investment will be repaid 2.35X (or $822.5MM) by FY38. This would be $5.96B in cumulative sales. Our forecast results in an XXXX% IRR = "low double digits" per RPRX  XXXXX engagements  **Related Topics** [digits](/topic/digits) [iranian rial](/topic/iranian-rial) [$596b](/topic/$596b) [$8225mm](/topic/$8225mm) [$350mm](/topic/$350mm) [pres](/topic/pres) [investment](/topic/investment) [$sndx](/topic/$sndx) [Post Link](https://x.com/NightOwlBiotech/status/1939425044809064712)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Night Owl Biotech Research Group @NightOwlBiotech on x 1157 followers
Created: 2025-06-29 20:45:38 UTC
A $SNDX $INCY Niktimvo revenue forecast using $RPRX data points per its 11/24 investor pres. RPRX notes its $350MM investment will be repaid 2.35X (or $822.5MM) by FY38. This would be $5.96B in cumulative sales. Our forecast results in an XXXX% IRR = "low double digits" per RPRX
XXXXX engagements
Related Topics digits iranian rial $596b $8225mm $350mm pres investment $sndx
/post/tweet::1939425044809064712